Currency in USD
Earnings estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|
No. of analysts | 5 | 5 | 5 | 5 |
Avg. Estimate | 2.01 | 2.51 | 10.33 | 11.77 |
Low estimate | 1.86 | 2.25 | 9.9 | 11.45 |
High estimate | 2.2 | 2.98 | 11.19 | 12.03 |
Year ago EPS | 3 | 2.33 | 11.78 | 10.33 |
Revenue estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|
No. of analysts | 5 | 5 | 5 | 5 |
Avg. Estimate | 645.79M | 661.04M | 2.65B | 2.79B |
Low estimate | 636.72M | 642.3M | 2.61B | 2.74B |
High estimate | 656.49M | 693.53M | 2.7B | 2.86B |
Year ago sales | 697.96M | 632.1M | 2.67B | 2.65B |
Sales growth (year/est) | -7.50% | 4.60% | -0.80% | 5.30% |
Earnings history | 29/06/2023 | 29/09/2023 | 30/12/2023 | 30/03/2024 |
---|
Est. EPS | 2.68 | 2.78 | 2.82 | 2.15 |
Actual EPS | 3 | 2.33 | 3.1 | 2.29 |
Difference | 0.32 | -0.45 | 0.28 | 0.14 |
Surprise % | 11.90% | -16.20% | 9.90% | 6.50% |
EPS trend | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|
Current estimate | 2.01 | 2.51 | 10.33 | 11.77 |
7 days ago | 2.01 | 2.51 | 10.33 | 11.77 |
30 days ago | 2.01 | 2.53 | 10.39 | 11.83 |
60 days ago | 1.95 | 2.51 | 10.24 | 11.79 |
90 days ago | 2.29 | 2.59 | 10.56 | 12 |
EPS revisions | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | N/A | N/A |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | BIO | Industry | Sector(s) | S&P 500 |
---|
Current qtr. | -33.00% | N/A | N/A | N/A |
Next qtr. | 7.70% | N/A | N/A | N/A |
Current year | -12.30% | N/A | N/A | N/A |
Next year | 13.90% | N/A | N/A | N/A |
Next 5 years (per annum) | 17.80% | N/A | N/A | N/A |
Past 5 years (per annum) | 11.12% | N/A | N/A | N/A |